Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insulet

304.63
+1.010.33%
Post-market: 304.00-0.6300-0.21%18:37 EDT
Volume:670.64K
Turnover:204.90M
Market Cap:21.44B
PE:54.90
High:308.79
Open:299.61
Low:299.61
Close:303.62
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities

Reuters
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop

Reuters
·
24 Feb

BUZZ-Bernstein raises Insulet's PT on robust insulin device demand

Reuters
·
24 Feb

Bernstein Adjusts Price Target on Insulet to $335 From $315, Keeps Outperform Rating

MT Newswires Live
·
24 Feb

Insulet Corp : Bernstein Raises Target Price to $335 From $315

THOMSON REUTERS
·
24 Feb

Robust Growth Prospects and Market Leadership Drive ‘Buy’ Rating for Insulet

TIPRANKS
·
23 Feb

Insulet’s Financial Challenges: Navigating Pandemic Risks and Cybersecurity Threats

TIPRANKS
·
22 Feb

Insulet’s Earnings Highlight Omnipod Success Amid Challenges

TIPRANKS
·
22 Feb

Insulet Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
22 Feb

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst

Benzinga
·
22 Feb

Insulet (NasdaqGS:PODD) Reports Q4 Earnings and Offers 2025 Revenue Growth Guidance

Simply Wall St.
·
22 Feb

BUZZ-Insulet falls as analysts see pricing headwinds in Q1

Reuters
·
22 Feb

Insulet Price Target Raised to $328.00/Share From $294.00 by Raymond James

Dow Jones
·
22 Feb

Insulet Is Maintained at Overweight by Wells Fargo

Dow Jones
·
21 Feb

Raymond James Adjusts Insulet Price Target to $328 From $294

MT Newswires Live
·
21 Feb

PODD Stock Falls Despite Q4 Earnings and Revenue Beat, Margins Rise

Zacks
·
21 Feb

Insulet price target raised to $328 from $294 at Raymond James

TIPRANKS
·
21 Feb

Insulet Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
21 Feb

Insulet (PODD) Receives a Hold from Stifel Nicolaus

TIPRANKS
·
21 Feb

Insulet Corp : Leerink Partners Raises Target Price to $314 From $290

THOMSON REUTERS
·
21 Feb